Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Model-informed optimal dose selection of golcadomide in combination with R-CHOP in patients with previously untreated aggressive B-cell lymphoma.
Journal: British journal of clinical pharmacology
Published: March 17, 2026
Transcriptomic classification of diffuse large B-cell lymphoma identifies a high-risk activated B-cell-like subpopulation with targetable MYC dysregulation.
Journal: Nature communications
Published: August 30, 2023
Clinical outcomes in patients relapsed/refractory after ≥2 prior lines of therapy for follicular lymphoma: a systematic literature review and meta-analysis.
Journal: BMC cancer
Published: May 24, 2022
Carfilzomib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma: A Phase I Trial.
Journal: Clinical lymphoma, myeloma & leukemia
Published: October 22, 2020
A phase I study of targeted, dose-escalated intravenous busulfan in combination with etoposide as myeloablative therapy for autologous stem cell transplantation in acute myeloid leukemia.
Journal: Clinical lymphoma, myeloma & leukemia
Published: September 18, 2014
FLT3 inhibitors in AML: are we there yet?
Journal: Current hematologic malignancy reports
Published: April 01, 2014
Showing 1-6 of 6
Last Updated: 09/26/2026